HK Stock MarketDetailed Quotes

03737 ZHONGZHIPHARM

Watchlist
  • 0.930
  • 0.0000.00%
Market Closed Dec 13 16:08 CST
803.15MMarket Cap6.60P/E (TTM)

About ZHONGZHIPHARM Company

Founded in 1993, Zhongzhi Pharmaceutical Group is a private technology enterprise integrating scientific research, production, sales, and drug retail chains. It has five subsidiaries: Zhongshan Hang Seng Pharmaceutical Co., Ltd., Zhongshan Zhongzhi Chinese Medicine Tablet Co., Ltd., Zhongshan Zhongzhi Pharmacy Chain Co., Ltd., Zhongzhi Pharmaceutical (Hong Kong) Co., Ltd., and Zhongshan Zhongzhi Food Technology Co., Ltd., and has a number of designated procurement bases for Chinese herbal medicines, and a complete pharmaceutical production and operation industry chain. After years of development, the Sino-Chilean pharmaceutical industry has embarked on a path of collaborative development in production, academia, and research. The company is committed to the path of innovation and development of traditional Chinese medicine, continuously improving the quality standards of existing proprietary Chinese medicine products, developing new types of safe and healthy traditional Chinese medicine products with independent intellectual property rights; committed to cultivating various scientific and technological talents to form a complete team of scientific and technological talents, and has successively established “science and technology service stations”, “postdoctoral workstations”, and “academician workstations”; committed to the construction of scientific and technological platforms, and has carried out in-depth and extensive cooperation with research institutes, and has successively set up “industry-university-research demonstration bases” and “innovative traditional Chinese medicine research and development demonstration bases” “Graduate students in Chinese Pharmacy “Innovative Training Center”, etc. In 2014, it was approved by the state to establish a “Key Research Laboratory for Traditional Chinese Medicine Breaking the Wall Tablet Technology and Application” of the State Administration of Traditional Chinese Medicine. The company's strong scientific and technological talent team and platform are the foundation for strengthening product strength and brand strength. Chinese herbal medicine breaking tablets are new fourth-generation Chinese medicine tablets. They have the high-end, convenient, and trendy characteristics of modern innovative traditional Chinese medicine. They are a new high-end health category manufactured on the basis of modern ultra-fine powder technology of traditional Chinese medicine and manufactured using a patented additive-free molding technology with independent intellectual property rights. They are the core variety of innovative traditional Chinese medicine from China and Chile. Zhongzhi Breaking the Wall has a number of independent intellectual property rights and patents, and the technical level is leading in the industry. In 2007, the Sino-Chilean traditional Chinese medicine wall-breaking tablet series was selected as a key new product project in Guangdong Province; in 2010, the Sino-Chilean traditional Chinese medicine wall-breaking tablet project was selected for the National Torch Program. Subsequently, the company became a pilot production unit and industry standard setting unit for traditional Chinese medicine wall-breaking tablets in Guangdong Province. “Creating a healthy life intelligently” is the core value of Zhongzhi. It guides China's commitment to improving and breaking through modern engineering technology for proprietary Chinese medicines, Chinese herbal medicines and health products. China's innovative technology and scientific and technological achievements in traditional Chinese medicine are the cornerstone of building a large health industry platform for enterprises, and will increasingly influence the future direction of the development of modern traditional Chinese medicine in China.

Company Profile

Symbol03737
Company NameZHONGZHIPHARM
ISINKYG989611085
Listing DateJul 13, 2015
Issue Price2.46
Shares Offered200.00M share(s)
FoundedSep 12, 2014
Registered AddressCayman Islands
Chairmanzhitian lai
Secretaryyongxin he
Audit InstitutionErnst & Young
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficeWindward 3, Regatta Office Park PO Box 1350 Grand Cayman KY1-1108 Cayman Islands
Head Office and Principal Place of BusinessRoom 10B, 15th floor, Cable TV Tower, 9 Hoi Shing Road, Tsuen Wan, New Territories, Hong Kong
Fiscal Year Ends12-31
Employees2736
MarketHong Kong motherboard
Phone0760-85331222
Fax0760-85318764
Emailhr@zeus.cn
Business Zhongzhi Pharmaceutical Holdings Co., Ltd. is a Chinese investment holding company. The company is mainly engaged in R&D, manufacturing and sales of proprietary Chinese medicines and tablets (including traditional tablets and new tablets). The company operates through three divisions: the pharmaceutical division, the operation of a chain of pharmacies in Zhongshan, Guangdong Province, and the operation of an online pharmacy. The company's brands include Zhongzhi, Liumian, and Cao Jinghua. The company mainly operates within China.

Company Executives

  • Name
  • Position
  • Salary
  • zhitian lai
  • Chairman of the Board, Executive Director, Remuneration Committee Members, Nomination Committee Members
  • 1.92M
  • yingfeng lai
  • CEO, Executive Director, Remuneration Committee Members, Nominate Remuneration Committee Members, Authorized Representative
  • 1.39M
  • yingsheng lai
  • Executive Director, Chief Financial Officer
  • 1.16M
  • xiaojun cao
  • Executive Director, Deputy General Manager
  • 1.36M
  • lixia jiang
  • Non-executive Directors
  • 270.00K
  • guanyun wu
  • Independent Non-Executive Director, Chairman of the Audit Committee, Nomination Committee Members, Remuneration Committee Members
  • 162.00K
  • jinhua huang
  • Independent Non-Executive Director, Chairman of the Nomination Committee, Remuneration Committee Chairman, Audit Committee Members
  • 162.00K
  • daihan zhou
  • Independent Non-Executive Director, Audit Committee Members, Nomination Committee Members, Remuneration Committee Members
  • 162.00K
  • weilin qiao
  • Vice President of Zhongzhi Pharmaceutical Group
  • --
  • guiquan he
  • Group Vice President
  • --
  • qiang ran
  • Group Vice President
  • --
  • manna shen
  • General Manager of Zhongzhi Chain
  • --
  • jiong chen
  • General Manager of Hang Seng Pharmaceutical
  • --
  • lin tang
  • Head of the Technical Department of Zhongzhi Pharmaceutical and Chief Engineer of Hang Seng Pharmaceutical
  • --
  • yongxin he
  • Authorized Representative, Company Secretary
  • --
Trending HK Stocks
HK Tech and Internet Stocks HK Tech and Internet Stocks

Stocks of companies primarily involved in technology and internet sectors in the HK stock market.Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Tech and Internet Stocks, ranked from highest to lowest based on real-time market data. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Tech and Internet Stocks, ranked from highest to lowest based on real-time market data.